Press Releases

Support of industry underscores pro-business commitment.

The Biotechnology Industry Organization (BIO) is pleased to announce the election of Rachel King, President and CEO, GlycoMimetics, Inc, as the new Chair of its Board of Directors for the 2013-2014 term, and the election of David Pyott, Chairman, President, & CEO, Allergan, Inc., as its new Board Secretary.

BIO issued the annual Scientific American Worldview Report and Bio-Innovation Scorecard. On Wednesday, April 24, the Scientific American Worldview Super Session will take place during the 2013 BIO International Convention.

Today, the 2013 U.S. National BioGENEius Challenge named the top 10 U.S. students finalists who will go on to compete in the next and final stage of the competition: the 2013 International BioGENEius Challenge on Tuesday.

New report to show areas with highest demand for life science workers.

Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.

Third annual conference to be held November 11-13, 2013 in Beijing, China.

BIO today asked EPA to consider changes to its proposed RIN Quality Assurance Program, which was drafted to address recent instances of fraud.

The Biotechnology Industry Organization (BIO) and the China Center for Pharmaceutical International Exchange (CCPIE) Announce Strategic Partnership to Expand the BIO Convention in China

The Biotechnology Industry Organization (BIO) named Dr. Jay Keasling as the recipient of its 2013 George Washington Carver Award for innovation in industrial biotechnology. 

Bill would allow emerging biotech companies to maintain a working relationship with their independent auditor.

BIO's Brent Erickson, executive vice president of the Industrial & Environmental Section, spoke at the Advanced Biofuel Leadership Conference in Washington, today, and said high prices for foreign oil have hastened the blend wall. The Renewable Fuel Standard forces us to solve our over-reliance on foreign oil.

Forum to confront issues and roadblocks to finding treatments and cures.

BIO stands ready to work with the Administration to develop policies that help spur innovation, foster economic opportunity, discover new cures and create jobs.  

Continued stable implementation of the RFS provides companies developing innovative new advanced and cellulosic biofuels confidence that the U.S. fuel market will remain open, if they can produce the fuels.

“We could not be more excited to celebrate the 10th anniversary of BIO’s World Congress to highlight the growth of the industry, particularly in Canada,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Section. 

Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.

BIO announced the companies confirmed to present at the 2013 BIO International Convention.

The Biotechnology Industry Organization (BIO) and BioFlorida commend the Florida Senate Committee on Health Policy for passage of Senate Bill 732 out of committee.

In statehouses around the country, lawmakers are beginning to address the complexities of cutting-edge biotech drugs and the regulatory issues related to the interchangeability of biosimilar medicines.

The BIO Alliance Zone and Translational Research Forum to be featured at the global event for biotechnology.

WASHINGTON, D.C. (March 8, 2013) – Whole Foods announced today that it will require the makers of food products sold in its stores to state on the label if a product contains an ingredient produced through agricultural biotechnology.

BIO and ASTA are pleased to announce that the American Farm Bureau Federation, American Soybean Association , and the National Corn Growers Association have become signatories to the Accord.